Product NDC: | 64764-119 |
Proprietary Name: | Colcrys |
Non Proprietary Name: | Colchicine |
Active Ingredient(s): | .6 mg/1 & nbsp; Colchicine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64764-119 |
Labeler Name: | Takeda Pharmaceuticals America, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022352 |
Marketing Category: | NDA |
Start Marketing Date: | 20090901 |
Package NDC: | 64764-119-03 |
Package Description: | 250 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64764-119-03) |
NDC Code | 64764-119-03 |
Proprietary Name | Colcrys |
Package Description | 250 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64764-119-03) |
Product NDC | 64764-119 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Colchicine |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20090901 |
Marketing Category Name | NDA |
Labeler Name | Takeda Pharmaceuticals America, Inc. |
Substance Name | COLCHICINE |
Strength Number | .6 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Interactions [MoA] |